, 2020 Background: In the United States, 5.7 million patients are admitted annually to intensive care units (ICU), with costs exceeding $82 billion. Although close monitoring and dynamic assessment of patient acuity are key aspects of ICU care, both are limited
Bihorac, Azra +6 more
core
Managing neurogenic orthostatic hypotension with droxidopa in a patient with Parkinson disease, atrial fibrillation, and hypertension [PDF]
, 2017 Ali Mehdirad +2 more
openalex +1 more source
Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease [PDF]
, 2017 Daniel Kremens +3 more
openalex +1 more source
Refractory orthostatic hypotension in a patient with a spinal cord injury: Treatment with droxidopa [PDF]
, 2017 Eva Canosa-Hermida +6 more
openalex +1 more source
Comparison of the Pharmacokinetics of Droxidopa After Dosing in the Fed Versus Fasted State and with 3-Times-Daily Dosing in Healthy Elderly Subjects [PDF]
, 2018 Jack J. Chen, L. Arthur Hewitt
openalex +1 more source
New and combined treatments for cirrhosis and portal hypertension: effects on hemodynamics and hepatic fibrosis in experimental animal models [PDF]
, 2016 La cirrosi, la causa més freqüent d'hipertensió portal (HTP) en els països occidentals, és considerada una malaltia amb múltiples fases, que evoluciona des d'etapes inicials asimptomàtiques a un estat de cirrosi descompensada amb diverses manifestacions ...
Rodríguez Navarro, Sarai +1 more
core +1 more source
Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients [PDF]
, 2018 Katherine E. McDonell +7 more
openalex +1 more source
Erratum to: Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension [PDF]
, 2017 Fiona Gupta +2 more
openalex +1 more source